De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Morinaga Milk Industry Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Morinaga Milk Industry heeft een totaal eigen vermogen van ¥282.7B en een totale schuld van ¥93.0B, wat de schuld-eigenvermogensverhouding op 32.9% brengt. De totale activa en totale passiva bedragen respectievelijk ¥546.9B en ¥264.2B. De EBIT Morinaga Milk Industry is ¥26.7B waardoor de rentedekking 445.3 is. Het heeft contanten en kortetermijnbeleggingen van ¥26.6B.

Belangrijke informatie

32.9%

Verhouding schuld/eigen vermogen

JP¥93.04b

Schuld

Rente dekkingsratio	445.3x
Contant	JP¥26.59b
Aandelen	JP¥282.66b
Totaal verplichtingen	JP¥264.20b
Totaal activa	JP¥546.86b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Return Trends At Morinaga Milk Industry (TSE:2264) Aren't Appealing

Sep 11

An Intrinsic Calculation For Morinaga Milk Industry Co., Ltd. (TSE:2264) Suggests It's 41% Undervalued

Jul 27

Morinaga Milk Industry Co., Ltd.'s (TSE:2264) Price Is Right But Growth Is Lacking

Jul 12

Additional Considerations Required While Assessing Morinaga Milk Industry's (TSE:2264) Strong Earnings

May 22

Returns On Capital At Morinaga Milk Industry (TSE:2264) Have Stalled

Apr 15

Improved Earnings Required Before Morinaga Milk Industry Co., Ltd. (TSE:2264) Shares Find Their Feet

Feb 28

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ¥206.0B ) 2264 } overtreffen de korte termijn passiva ( ¥167.7B ).

Langlopende schulden: De kortetermijnactiva 2264 ( ¥206.0B ) overtreffen de langetermijnschulden ( ¥96.5B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 23.5% ) 2264 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 2264 is de afgelopen 5 jaar gedaald van 62.2% naar 32.9%.

Schuldendekking: De schuld van 2264 wordt goed gedekt door de operationele kasstroom ( 60.8% ).

Rentedekking: De rentebetalingen op de schuld van 2264 worden goed gedekt door EBIT ( 445.3 x dekking).

Morinaga Milk Industry Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Return Trends At Morinaga Milk Industry (TSE:2264) Aren't Appealing

Morinaga Milk Industry Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

An Intrinsic Calculation For Morinaga Milk Industry Co., Ltd. (TSE:2264) Suggests It's 41% Undervalued

Morinaga Milk Industry Co., Ltd.'s (TSE:2264) Price Is Right But Growth Is Lacking

Morinaga Milk Industry Co., Ltd. to Report Q1, 2025 Results on Aug 08, 2024

Additional Considerations Required While Assessing Morinaga Milk Industry's (TSE:2264) Strong Earnings

Full year 2024 earnings: EPS misses analyst expectations

Morinaga Milk Industry Co., Ltd. Announces Resignation of Michio Miyahara as Representative Director, Effective June 27, 2024

Morinaga Milk Industry Co., Ltd. Announces Resignation of Michio Miyahara as Representative Director

Returns On Capital At Morinaga Milk Industry (TSE:2264) Have Stalled

Upcoming dividend of JP¥60.00 per share

Morinaga Milk Industry Co., Ltd. to Report Fiscal Year 2024 Results on May 14, 2024

Improved Earnings Required Before Morinaga Milk Industry Co., Ltd. (TSE:2264) Shares Find Their Feet

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Morinaga Milk Industry Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024

Morinaga Milk Industry Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024

Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium B-3 Receives Approval of Individual Recognized Registration in South Korea

Second quarter 2024 earnings: EPS exceeds analyst expectations

Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the First Six Months Ended September 30, 2023 and for the Fiscal Year Ending March 31, 2024

Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium Longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil

Morinaga Milk Industry Co., Ltd. to Report Q2, 2024 Results on Nov 09, 2023

New minor risk - Earnings quality

First quarter 2024 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 18%

Morinaga Milk Industry Co., Ltd. to Report Q1, 2024 Results on Aug 09, 2023

Morinaga Milk Industry Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 30, 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Morinaga Milk Industry Co., Ltd., Annual General Meeting, Jun 29, 2023

Upcoming dividend of JP¥90.00 per share at 1.9% yield

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Morinaga Milk Industry Co., Ltd. (TSE:2264) entered into an agreement to acquire 20% stake in Morinaga Le May Vietnam Joint Stock Company from Le Van May and Do Thanh Tuan for VND 98 billion.

Morinaga Milk Industry Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Morinaga Milk Industry Co., Ltd. (TSE:2264) completed the acquisition of additional 33.27% stake in Nutrico Morinaga (Private) Limited from ICI Pakistan Limited (KASE:ICI) and 11 minority shareholders.

Morinaga Milk Industry Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2023

Price target decreased to JP¥4,798

Price target decreased to JP¥5,198

Mitsui & Co., Ltd. (TSE:8031) acquired Tokyo Dairy Co., Ltd. from Morinaga Milk Industry Co., Ltd. (TSE:2264).

Morinaga Milk Industry Co., Ltd. to Report Q2, 2023 Results on Nov 10, 2022

First quarter 2023 earnings: EPS misses analyst expectations

Morinaga Milk Industry Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months of Fiscal Year Ending March 31, 2023 and Full Fiscal Year Ending March 31, 2023

Price target decreased to JP¥5,808

Consensus forecasts updated

Price target decreased to JP¥6,125

Morinaga Milk Industry Co., Ltd. to Report Q1, 2023 Results on Aug 09, 2022

Morinaga Milk Industry Co., Ltd. Obtains the Registration of New Food Ingredient in China for Use of Probiotic Bifidobacterium Longum BB536 in Infant and Toddler Foods

Full year 2022 earnings: EPS misses analyst expectations

Morinaga Milk Industry Co., Ltd., Annual General Meeting, Jun 29, 2022

Price target decreased to JP¥6,610

Less than half of directors are independent

Morinaga Milk Industry Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022

Upcoming dividend of JP¥80.00 per share

Morinaga Milk Industry Co., Ltd. (TSE:2264) announces an Equity Buyback for 4,400,000 shares, representing 8.89% for ¥26,400 million.

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Morinaga Milk Industry Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Price target decreased to JP¥7,093

Second quarter 2022 earnings released: EPS JP¥161 (vs JP¥139 in 2Q 2021)

Price target increased to JP¥7,792

Morinaga Milk Industry Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable on June 30, 2021

Full year 2021 earnings released: EPS JP¥379 (vs JP¥377 in FY 2020)

Consensus forecasts updated

Upcoming dividend of JP¥60.00 per share

Morinaga Milk Industry Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021

New 90-day low: JP¥4,830

Third quarter 2021 earnings released: EPS JP¥104 (vs JP¥96.48 in 3Q 2020)

Revenue beats expectations, earnings disappoint

New 90-day low: JP¥4,870

Price target raised to JP¥6,300

Morinaga Milk’s Probiotic Bifidobacterium Breve A1 Improves Memory of Older Adults with Cognitive Dysfunction

Morinaga Milk Industry Co., Ltd. to Report Q2, 2021 Results on Nov 11, 2020

Analyse van de financiële positie